Annual Accounts Receivable
N/A
31 December 2023
Summary:
Protagenic Therapeutics annual accounts receivable is not available.PTIX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
N/A
30 September 2024
Summary:
Protagenic Therapeutics quarterly accounts receivable is not available.PTIX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTIX Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
PTIX Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time |
Protagenic Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $5.30 M(+29.8%) |
| June 2011 | - | $4.08 M(-22.1%) |
| Mar 2011 | - | $5.24 M(+4.9%) |
| Dec 2010 | $4.99 M(-37.5%) | $4.99 M(-25.2%) |
| Sept 2010 | - | $6.68 M(-25.6%) |
| June 2010 | - | $8.98 M(-5.9%) |
| Mar 2010 | - | $9.54 M(+19.5%) |
| Dec 2009 | $7.99 M(-52.4%) | $7.99 M(-30.5%) |
| Sept 2009 | - | $11.49 M(+1.4%) |
| June 2009 | - | $11.34 M(-25.0%) |
| Mar 2009 | - | $15.11 M(-10.0%) |
| Dec 2008 | $16.79 M(+100.1%) | $16.79 M(-17.4%) |
| Sept 2008 | - | $20.32 M(-8.7%) |
| June 2008 | - | $22.27 M(+18.1%) |
| Mar 2008 | - | $18.86 M(+124.8%) |
| Dec 2007 | $8.39 M(+137.9%) | $8.39 M(+33.8%) |
| Sept 2007 | - | $6.27 M(+29.5%) |
| June 2007 | - | $4.84 M(+33.4%) |
| Mar 2007 | - | $3.63 M |
| Dec 2006 | $3.53 M(+63.7%) | - |
| Date | Annual | Quarterly |
|---|---|---|
| July 2004 | $2.15 M(-47.5%) | - |
| Apr 2003 | - | $3.73 M(+48.6%) |
| Jan 2003 | - | $2.51 M(-40.9%) |
| Oct 2002 | - | $4.25 M(+3.5%) |
| July 2002 | $4.11 M(-29.2%) | $4.11 M(-11.1%) |
| Apr 2002 | - | $4.62 M(-18.9%) |
| Jan 2002 | - | $5.69 M(-4.4%) |
| Oct 2001 | - | $5.95 M(+2.6%) |
| July 2001 | $5.80 M(-5.8%) | $5.80 M(-10.0%) |
| Apr 2001 | - | $6.45 M(+6.5%) |
| Jan 2001 | - | $6.06 M(-3.7%) |
| Oct 2000 | - | $6.29 M(+2.2%) |
| July 2000 | $6.16 M(+0.9%) | $6.16 M(+10.6%) |
| Apr 2000 | - | $5.57 M(-15.7%) |
| Jan 2000 | - | $6.60 M(+8.2%) |
| July 1999 | $6.10 M(+23.4%) | $6.10 M(+23.4%) |
| July 1998 | $4.95 M(+76.6%) | $4.95 M(-6.7%) |
| Apr 1998 | - | $5.30 M(+32.5%) |
| Jan 1998 | - | $4.00 M(+42.9%) |
| July 1997 | $2.80 M | $2.80 M |
FAQ
- What is the all time high annual accounts receivable for Protagenic Therapeutics?
- What is the all time high quarterly accounts receivable for Protagenic Therapeutics?
What is the all time high annual accounts receivable for Protagenic Therapeutics?
Protagenic Therapeutics all-time high annual accounts receivable is $16.79 M
What is the all time high quarterly accounts receivable for Protagenic Therapeutics?
Protagenic Therapeutics all-time high quarterly accounts receivable is $22.27 M